Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge – Phase II: Stage I

    Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge – Phase II: Stage I supports teams and organizations developing RNA-targeting prototypes to enable precision therapies for human disease.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

    This grant supports early-stage projects to develop innovative experimental and computational tools for comprehensive RNA analysis, aiming to overcome current limitations and advance research on RNA’s roles in health and disease.

    HHS-NIH11Forecasted Feb 15, 2027$500,000Forecasted

    RNomics Technology Enhancement Centers

    This grant will fund centers to advance and improve technologies for comprehensive analysis and mapping of all RNA molecules in cells and tissues, supporting broad research on RNA’s roles in health and disease.

    HHS-NIH11Forecasted Feb 1, 2027$2,000,000Forecasted

    RNomics Molecular Standards

    This grant will fund the development, testing, and distribution of RNA molecular reference standards to improve benchmarking, reproducibility, and comparison of RNA research technologies.

    HHS-NIH11Forecasted Feb 15, 2027Forecasted

    NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

    Supports milestone-driven development of therapies for visual system diseases through two research phases totaling up to five years; clinical trials are not allowed.

    HHS-NIH11Due Feb 16, 2027$4,500,000

    Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

    Funding opportunity for advancing nanotechnology-based cancer treatments to improve effectiveness through innovative nanoparticle designs and cargos.

    HHS-NIH11Due May 17, 2027